Summit Global Investments Raises Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Summit Global Investments lifted its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 39.8% in the 1st quarter, Holdings Channel reports. The firm owned 37,989 shares of the company’s stock after acquiring an additional 10,808 shares during the period. Summit Global Investments’ holdings in Phibro Animal Health were worth $811,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Sterling Capital Management LLC grew its holdings in shares of Phibro Animal Health by 2.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock worth $394,000 after purchasing an additional 448 shares in the last quarter. Rhumbline Advisers grew its holdings in shares of Phibro Animal Health by 0.6% during the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock worth $1,608,000 after purchasing an additional 484 shares in the last quarter. Los Angeles Capital Management LLC grew its holdings in shares of Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after purchasing an additional 503 shares in the last quarter. New York State Teachers Retirement System grew its holdings in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after purchasing an additional 775 shares in the last quarter. Finally, SG Americas Securities LLC grew its holdings in shares of Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after purchasing an additional 906 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Wall Street Analysts Forecast Growth

PAHC has been the subject of a number of recent research reports. Wall Street Zen upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Barclays boosted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Finally, Morgan Stanley boosted their target price on Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Phibro Animal Health has an average rating of “Hold” and a consensus target price of $20.00.

Phibro Animal Health Price Performance

Shares of PAHC stock opened at $24.58 on Friday. The stock has a market cap of $996.33 million, a price-to-earnings ratio of 51.21, a PEG ratio of 0.45 and a beta of 0.62. The business’s fifty day moving average is $20.52 and its 200 day moving average is $21.90. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The company had revenue of $347.80 million for the quarter, compared to analysts’ expectations of $352.41 million. Research analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be given a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 annualized dividend and a yield of 1.95%. Phibro Animal Health’s payout ratio is 61.54%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.